HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Damian G Downey Selected Research

tezacaftor

1/2022Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial.
11/2019Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Damian G Downey Research Topics

Disease

26Cystic Fibrosis (Mucoviscidosis)
02/2024 - 07/2012
4Lung Diseases (Lung Disease)
10/2023 - 01/2017
3Inflammation (Inflammations)
01/2022 - 09/2020
3Infections
09/2021 - 12/2015
2Pseudomonas Infections
10/2021 - 01/2017
2Persistent Infection
09/2021 - 01/2018
2Pneumonia (Pneumonitis)
01/2021 - 01/2018
1Rare Diseases (Rare Disease)
10/2023
1Bronchiectasis
01/2023
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2022
1Psychotic Disorders (Schizoaffective Disorder)
01/2022
1Headache (Headaches)
11/2021
1Exocrine Pancreatic Insufficiency
01/2017

Drug/Important Bio-Agent (IBA)

7Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
10/2023 - 01/2018
5Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 07/2012
4Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2016
3elexacaftorIBA
10/2023 - 11/2019
2trans-crotonin (CTN)IBA
02/2024 - 08/2021
2ivacaftor drug combination tezacaftorIBA
10/2023 - 01/2021
2ivacaftorIBA
01/2022 - 11/2019
2Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2020
2tezacaftorIBA
01/2022 - 11/2019
2Anti-Infective Agents (Microbicides)IBA
09/2021 - 10/2020
2ChloridesIBA
11/2019 - 01/2017
1Nucleic AcidsIBA
10/2023
1C-Reactive ProteinIBA
01/2023
1acebilustatIBA
11/2021
1riociguatIBA
11/2021
1leukotriene A4 hydrolaseIBA
11/2021
1Oxygen (Dioxygen)IBA
10/2021
1Azithromycin (Zithromax)FDA LinkGeneric
10/2021
1lenabasum (ajulemic acid)IBA
01/2021
1CB2 Cannabinoid ReceptorIBA
01/2021
1CannabinoidsIBA
01/2021
1AlginatesIBA
10/2020
1OligosaccharidesIBA
10/2020
1PowdersIBA
10/2020
1Sodium ChlorideFDA LinkGeneric
01/2020
1Enterotoxins (Enterotoxin)IBA
01/2020
1Lysine (L-Lysine)FDA Link
11/2017
1AztreonamFDA LinkGeneric
11/2017
1ThymidineIBA
01/2017
1Poly TIBA
01/2017
1GuanineIBA
01/2017
1IronIBA
12/2015
1Heme (Haem)IBA
12/2015
1HaptoglobinsIBA
12/2015
1Chelating AgentsIBA
12/2015
1Protein Isoforms (Isoforms)IBA
12/2015

Therapy/Procedure

7Therapeutics
10/2023 - 09/2020
1Lung Transplantation
10/2021
1Polypharmacy
10/2018